TEVA icon

Teva Pharmaceuticals

30.09 USD
+0.63
2.14%
At close Updated Mar 17, 4:00 PM EDT
Pre-market
After hours
30.18
+0.09
0.3%
1 day
2.14%
5 days
-4.11%
1 month
-12.55%
3 months
0.1%
6 months
63.71%
Year to date
-2.78%
1 year
80.07%
5 years
157.18%
10 years
-43.76%
 

About: Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Employees: 32,842

0
Funds holding %
of 8,085 funds
0
Analysts bullish %
of 5 analysts
0
Positive news %
of 17 articles
Price charts implemented using Lightweight Charts™